Home / Recalls / Carolina Infusion / D-1523-2022

D-1523-2022 Class II

Recalled by Carolina Infusion — Ridgeland, SC

Recall Details

Product Type
Drugs
Report Date
September 21, 2022
Initiation Date
August 26, 2022
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3 vials

Product Description

TEST CYP/DHEA (Sesame Oil) 100 MG/2.5 MG/ML Injection, 3 ML and 6 ML vials, Rx only, Carolina Infusion LLC, 95 Bees Creek Road, Ridgeland, SC 29936.

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

Nationwide in the USA.

Code Information

Lots: 07182022@9 BUD: 10/16/2022; 07272022@15 BUD: 10/25/2022

Other recalls by Carolina Infusion

  • D-1522-2022 Class II — TEST CYP (Grapeseed) 200 MG/ML Injectable, 10 ML vial, Rx only, Carolina Infusio (August 26, 2022)
  • D-1525-2022 Class II — TEST CYP/PROP (50:50) 100 MG/100 MG/ML Injectable, 12.6 ML vial, Rx only, Caroli (August 26, 2022)
  • D-1527-2022 Class II — TRI-MIX 30/1/20 Injectable, 5 ML vial, Rx only, Carolina Infusion LLC, 95 Bees C (August 26, 2022)
  • D-1530-2022 Class II — TRI-MIX 30/2/20 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees (August 26, 2022)
  • D-1516-2022 Class II — MIC/B12 25/50/50/1 MG/ML Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, (August 26, 2022)
  • D-1520-2022 Class II — Semaglutide/Cyanocobalamin 10/2 MG/ML Injectable, 0.4 ML syringe, Rx only, Carol (August 26, 2022)
  • D-1515-2022 Class II — L-Carnitine 500 mg/mL Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 (August 26, 2022)
  • D-1524-2022 Class II — TEST CYP/DHEA (Sesame) 200 MG/2.5 MG/ML Injectable, 10 ML vial, Carolina Infusio (August 26, 2022)
  • D-1519-2022 Class II — Semaglutide/Cyanocobalamin 5/2 MG/ML Injectable, 0.2 ML syringe, Rx only, Caroli (August 26, 2022)
  • D-1528-2022 Class II — TRI-MIX 30/1/40 Injectable, 10 ML vial, Rx only, Carolina Infusion LLC, 95 Bees (August 26, 2022)